Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/08 → 10/15/19 |
Funding
- Pfizer Inc.: $115,725.00
An International, Multi-Center, Prospective, Observational Study of the Safety of Maraviroc Used With Optimized Background Therapy in Treatment Experienced HIV 1 Infected Patients
- Greenberg, Richard (PI)